Navigation Links
Biochemist and Geneticist Ronald W. Davis Receives $500,000 Gruber Genetics Prize for Pioneering Work in the Development of Biotechnologies that Have Significantly Advanced the Fields of Molecular Genetics and Genomics

NEW YORK, June 8, 2011 /PRNewswire/ -- Ronald W. Davis, PhD, a pioneer in innovative biotechnologies, particularly the development and practical application of recombinant DNA and genomic methods to biological organisms, will receive the 2011 Genetics Prize of The Peter and Patricia Gruber Foundation.

Davis, 69, has spent most of his professional life at Stanford University, where he is a professor of biochemistry and genetics. He also serves as director of the Stanford Genome Technology Center, a position he has held since 1994.

He will receive the award on October 13 in Montreal, during the annual meeting of the American Society of Human Genetics, which is being held in conjunction with the 12th International Congress of Human Genetics.  Davis will also deliver a lecture at the conference.

"Ron Davis' innovations have resulted in remarkable advances in modern molecular genetics. I am delighted that he is the 2011 Gruber Genetics Prize recipient," says Gruber and Nobel laureate Elizabeth Blackburn, the Morris Herzstein Professor of Biology and Physiology in the Department of Biochemistry and Biophysics at the University of California, San Francisco.

Davis' impact on biomedical research has been broad and profound. In 1968, while still a graduate student at the California Institute of Technology, he developed one of the first mapping methods for DNA, as well as heteroduplex technology, which made imaging the pairing of two genomes possible. After he moved to Stanford in 1972, Davis created some of the earliest cloning vectors - DNA molecules that carry foreign DNA into a host cell, where the foreign DNA can then be replicated.

A string of other technologies and discoveries quickly followed. Working on the genome and biology of Saccaharomyces cerevisiae (baker's yeast), Davis' lab developed the first artificially constructed chromosomes, which are now routinely used to clone large genes and to map complex genomes. In 1979, Davis co-authored a seminal paper that described the very first case of what is now known as genome editing, the ability to replace any nucleotide in the yeast genome with any other nucleotide.

In 1980, in another landmark paper - one of the most highly cited in the field of human genetics - Davis and his team described how sequence variants in the genomes of humans and other species could provide genetic markers for making a genetic and physical map of the human genome. That paper helped launch the field of genomics. A few years later, Davis' lab showed how DNA libraries could be searched with protein-finding antibodies, a technique that has made it possible for scientists to identify genes for important proteins, including in humans.

During the 1990s, Davis contributed to the development of the very first microarrays, tools that enable scientists to analyze the gene expression of thousands of genes simultaneously. He then went on to help standardize this technology, paving the way for other scientists to use it for clinical applications. In recent years, his lab had produced sequences of several yeast chromosomes, part of the Escherichia coli genome, part of the Arabidopsis thalialiana genome (Arabidopsis is a plant widely used in the study of genetics), part of the human genome, and part of the genome of Plasmodium falciparu (a parasite that causes malaria in humans). Davis continues to develop new biotechnologies. DNA nanotechnology is a particular current focus.

"I really enjoy working on problems that others think are unsolvable," he says.

Additional Information The Peter and Patricia Gruber Foundation honors and encourages educational excellence, social justice and scientific achievements that better the human condition. For more information about Foundation guidelines and priorities, please visit

For more information on the Gruber Prizes e-mail or contact Bernetia Akin of the Gruber Foundation at +1 (340) 775-4430 or by mail 140 W 57th St Suite 10C New York, NY 10019.

The full release with Prize citation, other media materials and additional background information on the Gruber Prizes can be found at our online newsroom:

By agreement made in the spring of 2011, the Gruber Foundation has now been established at Yale University.Media Contact:

Foundation Contact:Cassandra OrylBernetia AkinLunchbox Communications

The Peter and Patricia Gruber Foundation+1 202-309-2263

+1 340-775-4430

SOURCE The Peter and Patricia Gruber Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. From GED to PhD: Borough of Manhattan Community Colleges Brian Olson Faces Academic Deficits Only to Be Rewarded with Acceptance to CUNYs PhD Program in Biochemistry
2. American Society for Biochemistry and Molecular Biology Reacts to District Court Stem-Cell Ruling
3. Mathematics and Biochemistry Research Earn Top Prize at Nations Premier High School Science Competition
4. Update: Georgia and North Carolina Teens Honored for Research in Biochemistry and Genetics in Nations Premier High School Science Competition
5. Max Planck Institute of Biochemistry Uses MathWorks Tools in Its Quest to Cure Cancer : Institute Accelerates Reconstruction of Key Protein Complexes Using MATLAB and Parallel Computing Toolbox
6. Mindray Appoints Mr. Ronald Ede as Chief Financial Officer
7. AMT CEO Ronald Lorijn Steps Down
8. [video] Ronald Andrews, CEO of Clarient, Inc. Discusses Agreement With University of Pennsylvania School of Medicine on WallSt.nets 3-Minute Press Show
9. Governor Gray Davis Joins Genesis Biopharma as Chairman of Corporate Advisory Board
10. Jack Davis, Diagnostics Industry Executive, Joins the HistoRx Board of Directors
11. Davis Phinney Foundation Launches Exercise-Focused Tools to Help People Live Well With Parkinsons Disease
Post Your Comments:
(Date:10/12/2015)... October 12, 2015 LabStyle Innovations ... Management Solution, today announced its Medical Director, Dr. ... at MobiHealth,s 5th EAI International Conference on Wireless ... through innovations in mobile and wireless technologies," the conference ... from October 14 - 16, 2015. The conference ...
(Date:10/12/2015)... ... , ... NeuMedics Inc., is a specialty biopharmaceutical company focused on identifying and ... be administered as an eye drop, announced today it has been selected to present ... place October 25th to October 28th at The Cleveland Clinic, Cleveland, Ohio. The ...
(Date:10/10/2015)... Oktober, 2015 Am 8. Oktober hat ... Partei für Kalifornien) ihre Würdigung der International Plasma ... die Aufzeichnungen des Kongresses eintragen lassen. Die IPAW ... (PPTA) und ihren Mitgliedsunternehmen unterstützt. Ihre Ziele ... Bewusstseins über Plasmaspenden weltweit , Würdigung des ...
(Date:10/9/2015)... 9, 2015  DePuy Synthes Trauma* announced today the ... ®  Technology**, the only pre-hydrated demineralized cancellous bone ... (foot and ankle, hand and wrist), including fusion, and ... at the 2015 Orthopaedic Trauma Association (OTA) Annual Meeting. ... for new bone growth) and osteoinductive 2,3 (stimulates ...
Breaking Biology Technology:
(Date:9/28/2015)... 28, 2015  The monitoring of vital signs, ... temperature, is an essential component of patient assessment. ... deterioration in a patient,s condition. However, in general ... typically taken during routine observation rounds only once ... deteriorates between these observation rounds, the warning signs ...
(Date:9/26/2015)... 2015  Results of a TactioRPM pilot project ... at the Stanford Medicine X Conference. In a ... Connected Health Devices and Pharmacogenomics", Roger Simard ... explain how senior patients equipped with connected health ... via the TactioRPM remote patient monitoring platform were ...
(Date:9/10/2015)... 2015 Report Details Emerging ... Opportunities and Revenue Prospects to Help You Stay ... especially new drug classes? Get the latest technological ... exclusive market data and industry knowledge, benefitting your ... opportunities and sales predictions. Visiongain,s new study ...
Breaking Biology News(10 mins):